Literature DB >> 14824401

The pathogenesis of infection with a virulent (CG 179) and an avirulent (B) strain of Newcastle disease virus in the chicken. II. Development of antibody.

D T KARZON, F B BANG.   

Abstract

Circulating antibody appeared in the convalescing NDV-infected chicken concomitantly with the disappearance of virus from the tissues. The antigenic response to the CG 179 and B strains was demonstrated to be approximately equal. The neutralization test in the embryo and the hemagglutination inhibition technique yielded parallel results in the measurement of antibody early in convalescence, but late in convalescence the hemagglutination inhibition titers were relatively lower. This disparity indicates the possible duality of the antibodies. There was a wide ratio between the neutralizing antibody titers found in the brain and in the serum after an asymptomatic infection with NDV. The antibody level in the brain appeared to be related to the extent of virus growth and damage in the central nervous system. It appeared likely that a major factor in determining the virulence of the CG 179 strain was the more rapid attainment in the central nervous system of high virus concentration which outstripped the defense mechanisms of the host.

Entities:  

Keywords:  NEWCASTLE DISEASE

Mesh:

Substances:

Year:  1951        PMID: 14824401      PMCID: PMC2136085          DOI: 10.1084/jem.93.3.285

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Agglutination of red cells altered by the action of Newcastle disease virus; the effect of chicken sera from infected birds on sensitized cells.

Authors:  F B BANG; R LIBERT
Journal:  Bull Johns Hopkins Hosp       Date:  1949-12

2.  The determination and significance of substances neutralizing Newcastle virus in human serum.

Authors:  F B BANG; M FOARD; D T KARZON
Journal:  Bull Johns Hopkins Hosp       Date:  1950-08

3.  QUALITATIVE DIFFERENCES IN THE ANTIGENIC COMPOSITION OF INFLUENZA A VIRUS STRAINS.

Authors:  W F Friedewald
Journal:  J Exp Med       Date:  1944-06-01       Impact factor: 14.307

4.  INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : I. NEUTRALIZING ANTIBODY IN THE CENTRAL NERVOUS SYSTEM IN RELATION TO CEREBRAL RESISTANCE.

Authors:  I M Morgan; R W Schlesinger; P K Olitsky
Journal:  J Exp Med       Date:  1942-10-01       Impact factor: 14.307

5.  ACCUMULATION OF ANTIBODIES IN THE CENTRAL NERVOUS SYSTEM.

Authors:  J Freund
Journal:  J Exp Med       Date:  1930-05-31       Impact factor: 14.307

6.  The mechanism of active cerebral immunity to equine encephalomyelitis virus; the local antigenic booster effect of the challenge inoculum.

Authors:  R W SCHLESINGER
Journal:  J Exp Med       Date:  1949-05       Impact factor: 14.307

7.  THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.

Authors:  G K Hirst
Journal:  J Exp Med       Date:  1942-01-01       Impact factor: 14.307

8.  IMMUNITY TO YELLOW FEVER ENCEPHALITIS OF MONKEYS AND MICE IMMUNIZED BY NEURAL AND EXTRANEURAL ROUTES.

Authors:  J P Fox
Journal:  J Exp Med       Date:  1943-06-01       Impact factor: 14.307

9.  Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses.

Authors:  D L WALKER; F L HORSFALL
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

  9 in total
  3 in total

1.  [Immunization experiments with experimentally induced variants of classical and atypical fowl plague virus].

Authors:  C HALLAUER; G KRONAUER
Journal:  Arch Gesamte Virusforsch       Date:  1960

2.  The pathogenesis of infection with a virulent (CG 179) and an avirulent (B) strain of Newcastle disease virus in the chicken. I. Comparative rates of viral multiplication.

Authors:  D T KARZON; F B BANG
Journal:  J Exp Med       Date:  1951-03       Impact factor: 14.307

3.  Adequacy of commercial lentogenic vaccines against Canadian strains of viscerotropic Newcastle disease virus.

Authors:  K Kaliannan; G L Seawright; J B Derbyshire
Journal:  Can J Comp Med       Date:  1975-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.